After months of delayed renovations due to COVID-19, our global HQ in Singapore has finally and officially moved into our new home at Science Park Drive. 

Despite the delay alongside global slowdown, our global headquarters have, on the contrary, worked tirelessly to escalate our progression in making quality healthcare more affordable and accessible for everyone.

From Singapore, the team made the most of its locational advantages as the axis of communications and commercial scalability in the APAC region. They collaborated seamlessly with global partners and our China team to enable a few noteworthy developments in short turnaround.

These include the investment into CorVent on surge support ventilator and more recently, the acquisition of Chocolate Touch®, the world's first drug-coated balloon catheter that combines therapeutic agent delivery with next-gen controlled dilation angioplasty technique. We are also in discussions with R&D strategic partners around the world on upcoming projects.

The speed and success of these developments underlined and validated Singapore as the prime choice for our global headquarters.

With circuit breaker measures gradually loosening and an anticipated return to normal in the horizon, here’s a sneak peek at our newly minted office spaces before they start filling up with our team members and global partners.